Companies / BIO

BIOME AUSTRALIA LIMITED

ASX:BIOHousehold & Personal Products
228.0M shares on issueASX (delayed) · snapshot 11 Sept 2026228.0M fully diluted+0.0% if every option and right converts$0.37price · delayed$84.4Mmarket cap · indicative
Minimal
Dilution risk

No major dilution pressure signals in current disclosures

MinimalVery high
Absolute levels — not a ranking against other companies.
Cash runwaycash-generative (no net burn)
Share-count growth (24m)4.1%
Raise cadence (24m)0 cash raises
Options & rights overhang0.0% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

BIOME AUSTRALIA LIMITED's ordinary share count grew 4.1% between September 2024 and March 2026, to 228M shares. The company has not raised capital in the past 24 months, and no proposed securities issues are pending. At the June 2026 quarter the company reported A$3.9M in available cash. The company reported non-negative net cash flow for the latest quarter, so no funding-runway figure applies.

AI-generated summary of this page's cited filings · updated 10 Sept 2026
Get told when this changes
Set up alerts
Daily email alerts cover risk-level moves, new raises, pending proposed issues and option expiries for the companies you follow.
0.0%
Options & rights overhang
0.0%
In-the-money supply
0
Raises · last 12 months
No net burn
Cash cover · cash-generative

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 228.0M per ASX (delayed) (snapshot 11 Sept 2026).
220.0M222.5M225.0M227.5MDec 24Oct 25Sept 26228.0M

Cash runway

—
The latest quarterly report shows no net cash burn, so there is no cash-out date.
$3.9M cash after burn from the quarter ended 30 June 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds. Filed with the quarterly report: $3.6M cash at quarter end (item 4.6). Our figure above carries the filed quarter-end balance forward at the reported spend rate and adds announced raise proceeds.
Free account
13 quarters on record — Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 30 June 2026.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityOn issue, per this filingSource
1 Apr 20263H · cancellationBIO : ORDINARY FULLY PAID228.0MAppendix 3H
30 Mar 20262A · quoted issueBIO : ORDINARY FULLY PAID228.0MAppendix 2A
19 Mar 20262A · quoted issueBIO : ORDINARY FULLY PAID224.5MAppendix 2A
19 Mar 20262A · quoted issueBIO : ORDINARY FULLY PAID227.0MAppendix 2A
17 Mar 20262A · quoted issueBIO : ORDINARY FULLY PAID224.5MAppendix 2A
Free account
18 filings on record — Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Capital raises

No equity raises in the last 24 months.
Free account
4 raises on record — Full raise history
Issue price, shares issued, brokers and stated purpose for every raise on record.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Forward supply

Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.

Free account
Forward supply calendar
Option expiries and proposed issues on one forward timeline, with the securities each could add.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Placement capacity

How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.

About 99% of the 15% placement capacity left — about 1% used by Appendix 3B filings in the last 12 months (estimate, as at 2026-09-12). Holder-approved issues and any later ratification are not deducted, so the true headroom can be higher.
Free account
Placement capacity — LR 7.1 / 7.1A
The filings behind the figure: every Appendix 3B in the window with what it says was issued under 7.1 and 7.1A, each row linked to its filing, and how many shares are left.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

No options or rights over unissued shares on record.

Director dealings

DateDirectorTypeSharesOptionsOtherValueSource
25 June 2026Blair Vega NorfolkBuy on-market100k——$25k3Y notice
12 June 2026Geoffrey SamBuy off-market72k——$20k3Y notice
10 June 2026Blair Vega NorfolkBuy on-market100k——$27k3Y notice
Free account
11 notices on record — Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Free account: 2 full company unlocks every month, no card.
Create free account

Latest announcements

8 Sept 2026$PNew Activated Probiotics launches for H1 FY27
26 Aug 2026$PBiome to Launch in China
25 Aug 2026$PPreliminary Final Report
28 July 2026$PQuarterly Activities & Cashflow Report
26 July 2026$PInternational Markets Presentation
26 July 2026Investor Webinar
30 June 2026$PFY26 Trading Update
25 June 2026Change of Director's Interest Notice
12 June 2026Change of Director's Interest Notice
12 June 2026Ceasing to be a substantial holder
10 June 2026Change of Director's Interest Notice
3 June 2026Change of Director's Interest Notice
2 June 2026$PBiome Signs Australian Manufacturing Agreement
2 June 2026Biome Investor Presentation June 2026
26 May 2026Investor Webinar
26 May 2026$PBMB18 clinical trial expands to dual site
11 May 2026$PProbiotical Exclusive Supply Agreement Extended
29 Apr 2026Change of Director's Interest Notice
28 Apr 2026Change of Director's Interest Notice
28 Apr 2026Revised Appendix 4C Quarterly Cash Flow Report

Headlines link to the source PDFs on the ASX announcements platform. Data as of 12 Sept 2026.